服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-CD3E;MS4A1/CD20 mAbs [Imvotamab Biosimilar] (MABL-4799) | MABL-4799 | ELISA, FACS, Functional assay, in vivo binding | M, Kappa;Kappa |
| Anti-CCR8/CKR-L1/CDw198 mAbs [Imzokitug Biosimilar] (MABL-4800) | MABL-4800 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SELP/CD62 mAbs [Inclacumab Biosimilar] (MABL-4801) | MABL-4801 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SDC1/CD138 mAbs [Indatuximab Biosimilar] (MABL-4802) | MABL-4802 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Gorivitug Biosimilar] (MABL-4769) | MABL-4769 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MAPT mAbs [Gosuranemab Biosimilar] (MABL-4770) | MABL-4770 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CTLA4/CD152 mAbs [Gotistobart Biosimilar] (MABL-4771) | MABL-4771 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PcrV type III secretion system;Polysaccharide synthesis locus (Pseudomonas) mAbs [Gremubamab Bi | MABL-4772 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-CLDN18;CD3E mAbs [Gresonitamab Biosimilar] (MABL-4773) | MABL-4773 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-C5 mAbs [Greziprubart Biosimilar] (MABL-4774) | MABL-4774 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD7 mAbs [Grisnilimab Biosimilar] (MABL-4775) | MABL-4775 | ELISA, FACS, Functional assay, in vivo binding | G2a, Lambda |
| Anti-F11 mAbs [Gruticibart Biosimilar] (MABL-4776) | MABL-4776 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-GLP1R mAbs [Gulgafafusp Biosimilar] (MABL-4777) | MABL-4777 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-IL17A mAbs [Gumokimab Biosimilar] (MABL-4778) | MABL-4778 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL23A mAbs [Guselkumab Biosimilar] (MABL-4779) | MABL-4779 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-TNFRSF13C/CD268/BAFFR/BR3 mAbs [Ianalumab Biosimilar] (MABL-4780) | MABL-4780 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD4 mAbs [Ibalizumab Biosimilar] (MABL-4781) | MABL-4781 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Ibramvibart Biosimilar] (MABL-4782) | MABL-4782 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-CSP1 mAbs [Ibentatug Biosimilar] (MABL-4783) | MABL-4783 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20 mAbs [Ibritumomab Biosimilar] (MABL-4784) | MABL-4784 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn